Evolus, Inc.
EOLSNasdaqCIK 1570562HealthcareFiscal year ends Dec 31
Reports and events: 153 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:56 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053468 |
| 2026-08-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053384 |
| 2026-08-0408:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000083 |
| 2026-07-0809:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000079 |
| 2026-06-1216:19 ET | 8-K | 5.07 Shareholder vote results | 0001570562-26-000076 |
| 2026-05-0417:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001570562-26-000066 |
| 2026-05-0416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000064 |
| 2026-04-2909:28 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001570562-26-000059 |
| 2026-03-1316:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001570562-26-000043 |
| 2026-03-0317:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-014001 |
| 2026-03-0316:25 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-013872 |
| 2026-01-0908:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-26-000003 |
| 2025-11-0517:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049673 |
| 2025-11-0516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049564 |
| 2025-09-0808:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000110 |
| 2025-08-0517:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001570562-25-000098 |
| 2025-08-0516:06 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001570562-25-000094 |
| 2025-06-0616:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001570562-25-000085 |
| 2025-05-2716:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000083 |
| 2025-05-0717:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001570562-25-000075 |
| 2025-05-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000074 |
| 2025-05-0516:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000069 |
| 2025-04-2517:00 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001570562-25-000066 |
| 2025-03-0416:40 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001570562-25-000020 |
| 2025-03-0416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000017 |
| 2025-01-2108:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000006 |
| 2024-11-0616:37 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001570562-24-000128 |
| 2024-11-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000127 |
| 2024-07-3117:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001570562-24-000116 |
| 2024-07-3116:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000114 |
| 2024-07-0116:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-24-000104 |
| 2024-06-1116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001570562-24-000098 |
| 2024-05-0717:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001570562-24-000080 |
| 2024-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000078 |
| 2024-04-2616:55 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001570562-24-000072 |
| 2024-04-0316:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001570562-24-000061 |
| 2024-03-1316:59 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001570562-24-000049 |
| 2024-03-0716:42 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001570562-24-000041 |
| 2024-03-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000038 |
| 2024-01-1617:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000003 |
| 2023-12-2008:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-23-000119 |
| 2023-11-0717:13 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001570562-23-000115 |
| 2023-11-0716:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000114 |
| 2023-08-1416:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001477932-23-006088 |
| 2023-08-0217:24 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001570562-23-000088 |
| 2023-08-0216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000086 |
| 2023-07-2708:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000082 |
| 2023-06-1416:39 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001570562-23-000079 |
| 2023-05-0917:12 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001570562-23-000070 |
| 2023-05-0916:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001570562-23-000068 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.